RESMED INC CDI COM USD0.004 (10 (RSMDF): Valuation
TTM figures as of June 30, 2026
RESMED INC CDI COM USD0.004 (10 trades at 21.4 times trailing earnings and a 5.06% free-cash-flow yield. On P/E that is higher than 100% of its own month-end history back to 2013. The Healthcare median P/E is 22.9.
Earnings yield 4.67%. Shareholder yield 2.99%. ROIC 25.9%. Piotroski F-score 7 of 9. Net cash $809.9M.
162 month-end valuation observations are on file, starting March 2013.
Sector comparison uses 2682 Healthcare names.
Frequently asked questions
Is RSMDF cheap versus its own history?
RESMED INC CDI COM USD0.004 (10 trades at 21.4 times trailing earnings and a 5.06% free-cash-flow yield. On P/E that is higher than 100% of its own month-end history back to 2013. The Healthcare median P/E is 22.9.
What is RSMDF's free-cash-flow yield?
RESMED INC CDI COM USD0.004 (10 currently yields 5.06% of market cap as trailing free cash flow.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.